Business
Press Release Nov 21 2023
Strides Pharma Science Limited has informed the Exchange regarding a press release dated November 21, 2023, titled "Strides receives USFDA approval for Levetiracetam Oral Solution".
About this update from Strides Pharma Science Ltd
[{"type":"text","content":" Strides Pharma Science Limited has informed the Exchange regarding a press release dated November 21, 2023, titled \"Strides receives USFDA approval for Levetiracetam Oral Solution\". View Attachment","length":329,"tagName":"div"}]